Foundation to Fight H-ABC BLOG
The Ripple Effect of Rare
On the last day of February, Rare Disease Day commands global attention — shining a light on conditions most people will never encounter, yet millions of families confront every single day.
This is not merely a date on the calendar. It is a declaration that rare does not mean invisible. It is a reminder that awareness, while vital, is only the beginning. Real progress demands relentless research, courageous advocacy, and an unwavering commitment to ensure that no life is diminished or delayed simply because a diagnosis is uncommon.
Strategic Philanthropy: Turning Awareness of H-ABC into Lasting Impact
Awareness brings attention, but progress requires strategy. For H-ABC Leukodystrophy, lasting impact depends on investments in data, diagnostics, and collaboration — long before outcomes are visible. This blog outlines how thoughtful philanthropy builds durable progress.
Why Early-Stage Funding Changes Everything in Rare Disease — Including H-ABC/TUBB4A
When fewer than 10% of rare diseases have an approved treatment, the issue is not always science. For families affected by H-ABC Leukodystrophy, early-stage research funding determines whether discovery can move forward at all. Understanding this gap changes how impact is created.
Rare Disease Is Not Small — It Is a System Hiding in Plain Sight
Rare disease is not defined by numbers alone. It is a shared system shaped by delayed diagnosis, limited data, and under-built infrastructure — challenges experienced every day by families affected by H-ABC Leukodystrophy. Recognizing this reality changes how progress is made.
The Bridge
The Bridge: For a long time, the story of rare disease was told through the lens of 'scarcity'—too few patients, too much risk, and not enough funding. But we are witnessing a historic pivot. We are moving from an era of managing symptoms to an era of 'curing the incurable.’
Five Years of Impact: Honoring Bob Ziarko
After five wonderful years of dedicated service, we share the bittersweet news that Robert “Bob” Ziarko will be retiring from the Foundation’s Board, effective December 2025.
Giving Tuesday & the Fight Against H-ABC: Why Your Gift Matters
Each year, Giving Tuesday offers a global pause—an opportunity to come together, to give, and to make an impact. For rare disease foundations like ours, this day does more than raise funds—it raises visibility, strengthens community, and accelerates progress.
Fall Wins for the H-ABC Community: Progress, People & Momentum
As we approach the end of October, we’re taking a moment to reflect on the incredible momentum our community has built this fall. From fundraising success to scientific progress to new leadership in our advisory team, this season has reminded us of the power of hope, collaboration, and determination. Every step forward is a step we take together- and this fall, we took some big ones.